The University of Kansas Cancer Center

https://www.kucancercenter.org/

 

The University of Kansas Cancer Center 2020 ASCO Highlights
A

2020 ASCO Update on Rectal Cancer: Should We Consider Total Neoadjuvant Therapy With mFOLFIRINOX a New Option for 1L Stage 3/4 Disease?

By The University of Kansas Cancer Center 2020 ASCO Highlights FEATURING Anwaar Saeed
By The University of Kansas Cancer Center 2020 ASCO Highlights FEATURING Anwaar Saeed
0 views
September 9, 2020
Comments 0
Login to view comments. Click here to Login

Featured Video

24:44
Indy Hematology Review

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Feat. R. Birhiray

Featured Video

23:35
University of Colorado Division of Hematology

2024 Updates in PV/ET

Feat. B. McMahon
2020 ASCO Highlights
10:04
The University of Kansas Cancer Center 2020 ASCO Highlights

2020 ASCO Update on ES-SCLC: Does the Addition of Anti-CTLA-4 Tremel…

Feat. J. Zhang
13:10
The University of Kansas Cancer Center 2020 ASCO Highlights

2020 ASCO NSCLC Highlights: Can We Consider Nivo + Ipi a Novel Chemo…

Feat. J. Zhang
08:14
The University of Kansas Cancer Center 2020 ASCO Highlights

2020 ASCO Highlights on NSCLC Targeted Therapy: T-DXd for HER2-Mutat…

Feat. J. Zhang
08:28
The University of Kansas Cancer Center 2020 ASCO Highlights

2020 ASCO Update on mCRC: Does T-DXd Have Potential in HER2+ Disease…

Feat. A. Saeed
12:44
The University of Kansas Cancer Center 2020 ASCO Highlights

2020 ASCO Update on Rectal Cancer: Should We Consider Total Neoadjuv…

Feat. A. Saeed
11:42
The University of Kansas Cancer Center 2020 ASCO Highlights

2020 ASCO Update on MSI-H mCRC: Is Pembrolizumab More Beneficial Tha…

Feat. A. Saeed
09:40
The University of Kansas Cancer Center 2020 ASCO Highlights

2020 ASCO Update on Gastroesophageal Cancer: Is Cabozantinib + Durva…

Feat. A. Saeed
09:55
The University of Kansas Cancer Center 2020 ASCO Highlights

ASCO 2020 Updates on Epithelial Ovarian Cancer: How Effective Is Sec…

Feat. A. Jewell, C. Salyer
07:24
The University of Kansas Cancer Center 2020 ASCO Highlights

ASCO 2020 Updates on Cervical Cancer and GTD: Sequential Chemo vs. R…

Feat. A. Jewell, C. Salyer
14:55
The University of Kansas Cancer Center 2020 ASCO Highlights

2020 ASCO Update on Neoadjuvant Therapy in TNBC: Does Sequential AC/…

Feat. P. Sharma
06:08
The University of Kansas Cancer Center 2020 ASCO Highlights

2020 ASCO Update on Neoadjuvant Therapy in TNBC: How Effective Is th…

Feat. P. Sharma
18:35
The University of Kansas Cancer Center 2020 ASCO Highlights

ASCO 2020 Symptoms and Survivorship Highlights: Does Early Palliativ…

Feat. E. Wulff-Burchfield